Cancer
News Category
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft
Onco-Innovations Limited initiates polymer process development with Nanosoft Polymers to establish a scalable, reproducible platform for its lead nano...
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
GeoVax comments on recent U.S. government procurement of smallpox vaccine ACAM2000, reinforcing the strategic importance of sustained investment in or...
Helix BioPharma Strengthens Executive Leadership Ahead of U.S. Listing and Clinical Advancement
Helix BioPharma appoints Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to support its planned U.S. exchange listi...
Onco-Innovations Advances Manufacturing and Development of Novel PNKP Inhibitors for Hard-to-Treat Cancers
Onco-Innovations Ltd. is making progress in the development of PNKP inhibitors, a new class of DNA damage response therapies, with a key manufacturing...
FDA-Approved Drug May Enhance Immunotherapy for Rare Liver Cancer
Researchers at the University of Washington discovered that an existing FDA-approved drug could improve immunotherapy outcomes for fibrolamellar carci...
Warning Issued to Pharmacists About Diverted HIV Medicines Sold on Online Pharmacy-to-Pharmacy Platforms
ADAP Advocacy and the Partnership for Safe Medicines warn pharmacists that discounted HIV products from online P2P marketplaces are suspect under FDA ...
Janet McDowell Shares Memoir of Leukemia Survival at Los Angeles Times Festival of Books
Janet McDowell's memoir 'Chasing a Light in the Darkness' offers a powerful account of battling lymphocytic leukemia, highlighting resilience and the ...
Medicai Showcases AI-Powered Patient Record Solution at European Parliament's Romanian Digital Day
Medicai co-founder Andrei Blaj presented the company's AI-driven platform at the European Parliament, highlighting how it reduces clinician workload b...
Oncotelic Therapeutics Publishes Peer-Validation of Deciparticle Platform for Intravenous Drug Delivery
Oncotelic Therapeutics and Sapu Nano announced the publication of a peer-reviewed manuscript validating the Deciparticle nanoparticle platform, with i...
Stonegate Capital Partners Initiates Coverage on OS Therapies, Highlighting Regulatory and Financial Milestones
Stonegate Capital Partners initiated coverage on OS Therapies, emphasizing the FDA's RMAT designation and BLA number for OST-HER2, promising Phase 2b ...
Landmark MERLIN_001 Trial Shows Merlin CP-GEP Test Accurately Stratifies Melanoma Patients by Sentinel Node Metastasis Risk
The largest prospective study of a genomic test in cutaneous melanoma, published in JAMA Surgery, demonstrates that the Merlin CP-GEP Test can identif...
Resecting the Unresectable: Advances in Extracorporeal Liver Surgery Offer New Hope
A new review highlights how Chinese surgeons have refined extracorporeal liver surgery, enabling radical resection for patients previously deemed inop...
Cervical cancer trends in China plateau but disparities widen for older and rural women
A study analyzing 20 years of data reveals that while China's cervical cancer incidence and mortality rates have stabilized since 2016, older and rura...
Livestrong Foundation Launches Sweepstakes for Costa Rica Getaway to Support Cancer Survivors
The Livestrong Foundation partners with Charity Ace to offer a chance to win a luxury Costa Rica vacation while funding programs that improve quality ...
Izotropic Featured in NetworkNewsWire Editorial on AI-Driven Breast Cancer Imaging
Izotropic Corporation is highlighted in a NetworkNewsWire editorial for its IzoView Breast CT Imaging System, which uses AI to improve breast cancer d...
Soligenix Advances HyBryte as Potential First-Line CTCL Treatment with Promising FLASH Results
Soligenix's HyBryte shows statistically significant efficacy in treating early-stage cutaneous T-cell lymphoma, with potential to become the first app...
New LED Therapy Selectively Kills Cancer Cells While Sparing Healthy Tissue
Researchers have developed a new LED-based therapy that targets and destroys cancer cells without harming healthy cells, potentially reducing harsh si...
Rita Case Donates $2 Million to Cleveland Clinic Weston Hospital, Naming the Rita and Rick Case Corridor
Rita Case's $2 million gift to Cleveland Clinic Weston Hospital supports research, education, and patient care, and names a major corridor in recognit...
Nanomedicine Breakthrough Redefines Drug Delivery, Enhancing Bioavailability in Oncology
Nanomedicine advances, particularly Oncotelic Therapeutics' Deciparticle platform, are improving drug bioavailability and targeting, potentially trans...
Scientists Uncover Possible Driver of ‘Chemo Brain’
A recent study reveals that chemotherapy-induced damage to the brain’s waste drainage network may cause the cognitive difficulties known as ‘chemo bra...
Aditxt Subsidiary Pearsanta Begins Enrollment in Clinical Study for Blood-Based Endometriosis Test
Pearsanta Inc., a subsidiary of Aditxt Inc., has initiated enrollment in a clinical study to validate its Mitomic Endometriosis Test, a non-invasive b...
Izotropic’s IzoView Breast CT System Poised to Transform Breast Cancer Imaging in Growing $9 Billion Market
Izotropic Corporation’s IzoView Breast CT Imaging System, combining high-resolution volumetric imaging with proprietary AI reconstruction, is position...
Dr. Hos Loftus Named 2025 Castle Connolly Top Doctor for Integrated Neurology and Psychology Care
Dr. Hos Loftus, founder of Carolinas Institute for Neurology and Psychology, has been recognized as a 2025 Castle Connolly Top Doctor for his holistic...
GeoVax Highlights IDSA Guidance Underscoring Need for Tailored COVID-19 Vaccines for Immunocompromised Patients
GeoVax Labs emphasizes new IDSA guidelines that reveal current COVID-19 vaccines provide inadequate protection for immunocompromised individuals, vali...
Oncotelic Therapeutics Featured in NetworkNewsWire Editorial on Nanomedicine Innovations in Oncology
Oncotelic Therapeutics highlights its Deciparticle platform in a NetworkNewsWire editorial, emphasizing how nanocarrier-based delivery systems are tra...
Glioblastoma Remission Rates Remain Low, Offering Little Hope for Patients
This article explains the low remission rates for glioblastoma, the most deadly primary brain cancer, and discusses factors influencing remission to h...
Olympus Launches NBI+TXI Observation Mode for EVIS X1 Endoscopy System
Olympus introduces a combined imaging mode that merges Narrow Band Imaging and Texture and Color Enhancement Imaging to enhance visualization for gast...
GeoVax Highlights Alignment of GEO-CM04S1 Clinical Data with New IDSA Guidelines for Immunocompromised COVID-19 Vaccination
GeoVax's Phase 2 data for its multi-antigen COVID-19 vaccine GEO-CM04S1 aligns with new IDSA guidelines calling for improved vaccines for immunocompro...
Nanomedicine Advances Target Drug Delivery Challenges in Oncology
Innovations in nanocarrier-based drug delivery systems, such as Oncotelic Therapeutics' Deciparticle platform, are poised to improve bioavailability a...
Oncotelic Therapeutics Highlighted in NetworkNewsWire Editorial on Nanomedicine Advances in Oncology
Oncotelic Therapeutics' Deciparticle platform is featured in a NetworkNewsWire editorial discussing how nanocarrier-based delivery systems are improvi...
Aditxt Announces 1-for-113 Reverse Stock Split Effective Nov. 3, 2025 to Regain Nasdaq Compliance
Aditxt will implement a 1-for-113 reverse stock split on Nov. 3, 2025, aiming to meet Nasdaq's minimum bid price requirement and maintain its listing.
NETEC Announces $37.5 Million Grant to Enhance Management of High-Consequence Infectious Diseases
The National Emerging Special Pathogens Training & Education Center (NETEC) has announced a $37.5 million grant to support 75 healthcare facilities in...
GeoVax Urges Congress to Act After BIO CEO Warns U.S. Could Lose Biotech Leadership Within Two Years
GeoVax Labs responds to BIO CEO John Crowley's Senate testimony that U.S. biotech leadership could be overtaken by China within two years, calling for...
Hancock Health and Arrive AI Launch Robotic Delivery Program to Transform Hospital Logistics
Hancock Health and Arrive AI have initiated a two-year partnership deploying autonomous robotic delivery stations for medical specimens, aiming to red...
ABVC BioPharma Receives Additional $100,000 Licensing Payment from OncoX, Totaling $695,950
ABVC BioPharma's oncology partner OncoX made a fifth licensing payment in 2025, demonstrating cash flow visibility and advancing ABVC's licensing-driv...
Oncotelic Therapeutics' Sapu003 Accepted for Presentation at 2025 San Antonio Breast Cancer Symposium
Oncotelic Therapeutics announced that its joint venture's investigational drug Sapu003, a novel formulation of everolimus, has been accepted for prese...
New Book 'After Cancer: Now What?' Offers Biblical Guidance for Post-Treatment Healing
Author Theresia Whitfield releases 'After Cancer: Now What? A Biblical Guide to Navigating Life After Cancer' to help survivors find emotional and spi...
Sapu Nano Initiates First In-Human Clinical Trial of Sapu-003, an Injectable Everolimus Formulation
Sapu Nano has launched the first in-human clinical trial of Sapu-003, an injectable version of Everolimus (Afinitor) designed to improve bioavailabili...
Soligenix Revamps Medical Advisory Board to Advance CTCL Drug HyBryte
Soligenix has updated its U.S. Medical Advisory Board for cutaneous T-cell lymphoma to support the clinical development of HyBryte, reflecting a strat...
Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at World ADC Congress 2025 and Host Webinar
Heidelberg Pharma announces upcoming presentation of promising clinical data from its Phase I/IIa trial of HDP-101 in relapsed/refractory multiple mye...
Pacylex and Heidelberg Pharma Present Zelenirstat ADC Data at World ADC Conference
Pacylex Pharmaceuticals and Heidelberg Pharma presented positive data showing that zelenirstat, when used as an ADC payload, demonstrates significantl...
Lung Cancer Screening Rates Remain Alarmingly Low in the U.S., New Report Finds
A recent report from the American Lung Association reveals that only a small fraction of eligible Americans undergo lung cancer screening, despite lun...
Kairos Pharma Reports Promising Phase 2 Trial Results for ENV105 in Metastatic Prostate Cancer
Kairos Pharma's Phase 2 trial of ENV105 shows 86% clinical benefit rate in advanced metastatic prostate cancer, potentially extending standard care ef...
Enhanced Natural Killer Cells Show Promise for Next-Generation Cancer Immunotherapy
Researchers at MIT and Harvard Medical School have engineered chimeric antigen receptor natural killer cells with modifications that prevent immune re...
Review Finds Significant Neurocognitive Decline in CNS Cancer Patients, Underscoring Need for Targeted Therapies
A recent review highlights that central nervous system cancers cause substantial neurocognitive decline due to tumor location and treatment effects, e...
Soligenix Advances SGX302 for Psoriasis, Targeting $67 Billion Dermatology Market
Soligenix reports encouraging early safety and biological activity from its phase 2a trial of SGX302 for mild-to-moderate psoriasis, positioning it as...
Soligenix Announces Q3 2025 Financial Results and Clinical Milestones for Psoriasis and CTCL Programs
Soligenix reported Q3 2025 financials, highlighting upcoming Phase 2a results for SGX302 in psoriasis and progress in its Phase 3 HyBryte study for CT...
Oncotelic Venture Sapu Nano Receives Ethics Approval for Intravenous Everolimus Trial in Breast Cancer
Sapu Nano, a venture of Oncotelic Therapeutics, has received ethics committee approval in Australia to begin clinical trials for Sapu003, an injectabl...